Charles River Laboratories International Inc. (CRL) Stock Forecast & Predictions

Charles River Laboratories International Inc. CRL: $335.03

251 Ballardvale St, Wilmington, Massachusetts, US. | Sector: Professional, Scientific, and Technical Services | Exchange: NEW YORK STOCK EXCHANGE, INC. | Web: https://www.criver.com/

  • Market Cap$16.27B
  • Change (52 Weeks)136.30%
  • Low (52 Weeks)$133.57
  • Charles River Laboratories International Inc. (CRL) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 31.25% are on Buy, 25.00% on Sell, and 43.75% Neutral.

    According to the market data, Charles River Laboratories International Inc. (CRL) stock price is $335.03 and the 52 weeks low is $133.57, which means the Charles River Laboratories International Inc. stock price is up 136.30% in the last 12 months.

    Charles River Laboratories International Inc. (CRL) Stock Price has been Trending Strongly with an ADX reading of 27.31 as per the Weekly Chart.

    A Upward trend indicates that Charles River Laboratories International Inc. (CRL) Stock Price may keep going up, with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 31.25% are indicating that CRL Stock price might rise further, 25.00% indicating that CRL Stock price might fall, and 43.75% are in a neutral position.

    Based on these technical algorithms, overall CRL stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Charles River Laboratories International Inc. (CRL) Stock Price Prediction By Analysts


    HighLowAverage
    $378.00$308.05$341.54
    $341.541.94% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for CRL set by the institutional analysts is $341.54 where High Estimate is $378.00, Median $340.68 and Low $308.05.

    The average price target for CRL by Institutional Analysts is $341.54, which is 1.94% Upside from the current price. So according to the Institutional Analysts, CRL Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Charles River Laboratories International Inc. (CRL) Stock Forecast Based on News Sentiment


    Neutral
    Based on 1 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of CRL consisting of positive and negative, it shows that Charles River Laboratories International Inc. had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so CRL stock price most likey won't have any reaction to last weeks news coverage.

    Charles River Laboratories International Inc. (CRL) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    Truist SecuritiesBuyMaintained
    Deutsche BankBuyMaintained
    CitigroupNeutralDowngraded
    KeyBancOverweightMaintained
    Morgan StanleyOverweightMaintained
    Argus ResearchBuyMaintained
    JefferiesBuyUpgraded
    KeyBancOverweightMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    B of A SecuritiesBuyUpgraded
    UBSBuyUpgraded
    Deutsche BankBuyMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Morgan StanleyOverweightMaintained
    JP MorganOverweightMaintained
    Credit SuisseNeutralMaintained
    CitigroupBuyMaintained
    JefferiesHoldDowngraded
    CitigroupBuyMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Wells FargoOverweightMaintained
    Morgan StanleyOverweightUpgraded
    BarclaysEqual-WeightMaintained
    JefferiesBuyMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Deutsche BankBuyInitiated
    Wolfe ResearchOutperformUpgraded
    Morgan StanleyEqual-WeightMaintained
    BairdOutperformMaintained
    CFRAStrong BuyMaintained
    Goldman SachsBuyUpgraded
    Wells FargoOverweightInitiated
    CitigroupBuyInitiated
    BairdOutperformMaintained
    KeyBancOverweightMaintained
    UBSNeutralMaintained
    Bank of AmericaNeutralDowngraded
    SunTrust Robinson HumphreyBuyMaintained
    BarclaysEqual-WeightMaintained
    KeyBancOverweightMaintained
    Morgan StanleyEqual-WeightMaintained
    RBC CapitalOutperformMaintained
    Raymond JamesOutperformMaintained
    BairdOutperformMaintained
    Credit SuisseNeutralMaintained
    BairdOutperformMaintained
    Morgan StanleyEqual-WeightMaintained
    ArgusBuyMaintained
    Raymond JamesOutperformUpgraded
    Credit SuisseNeutralMaintained
    JefferiesBuyMaintained
    BarclaysEqual-WeightMaintained
    RBC CapitalOutperformUpgraded
    Bank of AmericaBuyMaintained
    KeyBancOverweightUpgraded
    Mitsubishi UFJNeutralInitiated
    Morgan StanleyEqual-WeightMaintained
    SunTrust Robinson HumphreyBuyUpgraded
    JP MorganOverweightMaintained
    SunTrust Robinson HumphreyHoldDowngraded
    Evercore ISI GroupIn-LineInitiated
    ArgusBuyInitiated
    JefferiesBuyMaintained
    Bank of AmericaBuyMaintained
    JefferiesBuyMaintained
    RBC CapitalSector PerformInitiated
    Evercore ISI GroupBuyUpgraded
    Goldman SachsNeutralUpgraded
    BarclaysEqual-WeightUpgraded
    UBSSellDowngraded
    JefferiesBuyMaintained
    CitigroupNeutralMaintained
    Credit SuisseNeutralInitiated
    BarclaysUnderweightMaintained
    Gabelli & Co.BuyInitiated
    UBSNeutralMaintained
    Deutsche BankHoldMaintained
    JefferiesBuyMaintained
    BairdOutperformMaintained
    Wells FargoOutperformDowngraded
    Deutsche BankHoldMaintained
    Wells FargoMarket PerformUpgraded
    CitigroupNeutralMaintained
    Morgan StanleyEqual-WeightMaintained
    BarclaysUnderweightDowngraded
    Bank of AmericaBuyUpgraded
    Edward JonesBuyUpgraded
    JefferiesBuyMaintained
    BarclaysEqual-WeightMaintained
    Wells FargoUnderperformDowngraded
    SunTrust Robinson HumphreyNeutralDowngraded
    JefferiesBuyMaintained
    Deutsche BankHoldMaintained
    JefferiesBuyMaintained
    William BlairOutperformUpgraded
    JefferiesBuyMaintained
    Credit SuisseNeutralMaintained
    CitigroupNeutralMaintained
    Deutsche BankHoldMaintained
    JefferiesBuyMaintained
    SunTrust Robinson HumphreyBuyUpgraded
    Deutsche BankHoldMaintained
    JP MorganOverweightMaintained
    Credit SuisseNeutralMaintained
    SunTrust Robinson HumphreyNeutralInitiated
    CitigroupHoldMaintained
    KeyBancHoldInitiated
    CitigroupNeutralInitiated
    Bank of AmericaNeutralMaintained
    Raymond JamesMarket PerformUpgraded
    Deutsche BankHoldInitiated
    Cantor FitzgeraldBuyInitiated
    Credit SuisseNeutralInitiated
    UBSNeutralInitiated
    Goldman SachsSellDowngraded
    Sterne AgeeBuyInitiated
    Raymond JamesUnderperformDowngraded
    CitigroupSellDowngraded
    Wells FargoMarket PerformDowngraded
    Bank of AmericaNeutralInitiated
    ISI GroupNeutralMaintained
    JefferiesBuyUpgraded
    Sterne AgeeBuyMaintained
    Wells FargoOutperformUpgraded
    JP MorganOverweightUpgraded
    JefferiesHoldMaintained
    ISI GroupUnderweightInitiated
    Sterne AgeeBuyMaintained

    Charles River Laboratories International Inc. (CRL) Stock Earning Per Share (EPS) Forecast / Estimate


    $2.149
    The average consensus EPS for CRL is $2.149 with a high estimate of $2.363 and Low of $1.835 for the period 2021-06-30 and based on 15 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $2.33$1.81746472020-09-30


    The latest average Earning Per Share Estimate for Charles River Laboratories International Inc. is $2.15, which is lower than CRL's last EPS, $2.33. This means that Analysts are expecting Charles River Laboratories International Inc. to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Charles River Laboratories International Inc..

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $2.33$1.81746472020-09-30
    $1.58$1.27708440000000012020-06-30
    $1.84$1.49728460000000022020-03-31
    $2.01$1.8529462019-12-31
    $1.69$1.64874422019-09-30
    $1.63$1.56884312019-06-30
    $1.4$1.39543622019-03-31
    $1.49$1.40988932018-12-31
    $1.53$1.3963252018-09-30
    $1.62$1.47628672018-06-30
    $1.38$1.27525632018-03-31
    $1.4$1.26593400000000012017-12-31
    $1.3$1.23212932017-09-30
    $1.29$1.23106882017-06-30
    $1.29$1.14862252017-03-31
    $1.21$1.12014050000000022016-12-31
    $1.18$1.14461282016-09-30
    $1.2$1.11381792016-06-30
    $0.98$0.90959592016-03-31
    $1$0.9492992015-12-31
    $1.03$0.95220779999999992015-09-30
    $0.96$0.981722015-06-30
    $0.79$0.830222015-03-31
    $0.81$0.72189752014-12-31
    $0.86$0.80624262014-09-30
    $0.97$0.82511952014-06-30
    $0.82$0.74655160000000012014-03-31
    $0.73$0.68471942013-12-31
    $0.79$0.70765652013-09-30
    $0.73$0.721142013-06-30
    $0.69$0.71493860000000012013-03-31
    $0.64$0.60455572012-12-31
    $0.65$0.62936132012-09-30
    $0.75$0.6691252012-06-30
    $0.7$0.65794429999999992012-03-31
    $0.69$0.56143882011-12-31
    $0.57$0.58849672011-09-30
    $0.7$0.60816142011-06-30
    $0.61$0.55316692011-03-31
    $0.6$0.49961672010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).